Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic InterventionRoberto Buonaiuto, Carmine De Angelis, Pietro De Placido et al.|Biomolecules|2023Cited by 14
Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation typeRoberto Buonaiuto, Carmine De Angelis, Giuseppe Neola et al.|Frontiers in Oncology|2024Cited by 9
Abstract PO4-03-07: The impact of chemotherapy relative dose intensity on pathological complete response in patients with triple negative breast cancer treated with neoadjuvant chemotherapyRoberto Buonaiuto, Carmine De Angelis, Grazia Arpino et al.|Cancer Research|2024Cited by 1